Bioequivalence and Bioavailability Forum 20:15 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

weidson
Junior

Brazil,
2018-04-09 20:40

Posting: # 18658
Views: 733
 

 In vitro Bioequivalence for suspension ophthalmic [Regulatives / Guidelines]

Dear All,

Has anyone in this group ever performed an in vitro bioequivalence study with an ophthalmic suspension that was guided by the Guidance on Dexamethasone / tobramycin (reviewed June 2012, June 2013 and June 2016)? If yes, what is the acceptance criterion for bioequivalence? In the draft nothing is mentioned for the range of acceptance of the mortality rate of the microorganisms.

https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm308032.pdf

Thanks vary much.
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,783 posts in 4,003 threads, 1,258 registered users;
online 12 (0 registered, 12 guests [including 9 identified bots]).

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed